Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Low Molecular Weight Heparin Injection Supply, Demand and Key Producers, 2024-2030

date 04 Jun 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD4480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jun 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD3480.00

Add To Cart

Add To Cart

industry 04 Jun 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD4480.00

addToCart

Add To Cart

industry 04 Jun 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD3480.00

addToCart

Add To Cart